Kyeong Rok Choi

Dr. Kyeong Rok Choi

Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JRJegadeesh Raman
Jegadeesh Raman
JKJeongseon Kim
Jeongseon Kim
KCKyeong Rok Choi
Kyeong Rok Choi
HEHyunmin Eun
Hyunmin Eun
DYDongsoo Yang
Dongsoo Yang
SKSoo-Jin Kim
Soo-Jin Kim
Lactic acid bacteria (LAB) are significant groups of probiotic organisms in fermented food and are generally considered safe. LAB regulate soil organic matter and the biochemical cycle, detoxify hazardous chemicals, and enhance plant health. They are found in decomposing plants, traditional fermented milk products, and normal human gastrointestinal and vaginal flora. Exploring LAB identified in unknown niches may lead to isolating unique species. However, their classification is quite complex, and they are adapted to high sugar concentrations and acidic environments. LAB strains are considered promising candidates for sustainable agriculture, and they promote soil health and fertility. Therefore, they have received much attention regarding sustainable agriculture. LAB metabolites promote plant growth and stimulate shoot and root growth. As fertilizers, LAB can promote biodegradation, accelerate the soil organic content, and produce organic acid and bacteriocin metabolites. However, LAB show an antagonistic effect against phytopathogens, inhibiting fungal and bacterial populations in the rhizosphere and phyllosphere. Several studies have proposed the LAB bioremediation efficiency and detoxification of heavy metals and mycotoxins. However, LAB genetic manipulation and metabolic engineered tools provide efficient cell factories tailor-made to produce beneficial industrial and agro-products. This review discusses lactic acid bacteria advantages and limitations in sustainable agricultural development.

1 November 2016 in Biotechnology Advances
Verified
Journal Article
Closed access
KCKyeong Rok Choi
Kyeong Rok Choi
SLSang Yup Lee
Sang Yup Lee

27 August 2018 in Nature Catalysis
Verified
Journal Article
Closed access
PDF file
XZXin Rui Zhao
Xin Rui Zhao
KCKyeong Rok Choi
Kyeong Rok Choi
SLSang Yup Lee
Sang Yup Lee

1 December 2020 in Current Opinion in Chemical Biology
Verified
Journal Article
Closed access
KCKyeong Rok Choi
Kyeong Rok Choi
SJSong Jiao
Song Jiao
SLSang Yup Lee
Sang Yup Lee

27 June 2023 in Nature Reviews Bioengineering
Verified
Journal Article
Closed access
PDF file
KCKyeong Rok Choi
Kyeong Rok Choi
SLSang Yup Lee
Sang Yup Lee

24 April 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
JCJae Sung Cho
Jae Sung Cho
DYDongsoo Yang
Dongsoo Yang
CPCindy Pricilia Surya Prabowo
Cindy Pricilia Surya Prabowo
MGMohammad Rifqi Ghiffary
Mohammad Rifqi Ghiffary
THTaehee Han
Taehee Han
SLSang Yup Lee
Sang Yup Lee
Synthetic sRNAs allow knockdown of target genes at translational level, but have been restricted to a limited number of bacteria. Here, we report the development of a broad-host-range synthetic sRNA (BHR-sRNA) platform employing the RoxS scaffold and the Hfq chaperone from Bacillus subtilis. BHR-sRNA is tested in 16 bacterial species including commensal, probiotic, pathogenic, and industrial bacteria, with >50% of target gene knockdown achieved in 12 bacterial species. For medical applications, virulence factors in Staphylococcus epidermidis and Klebsiella pneumoniae are knocked down to mitigate their virulence-associated phenotypes. For metabolic engineering applications, high performance Corynebacterium glutamicum strains capable of producing valerolactam (bulk chemical) and methyl anthranilate (fine chemical) are developed by combinatorial knockdown of target genes. A genome-scale sRNA library covering 2959 C. glutamicum genes is constructed for high-throughput colorimetric screening of indigoidine (natural colorant) overproducers. The BHR-sRNA platform will expedite engineering of diverse bacteria of both industrial and medical interest.